Corus added to its network the Manuel Peña Capuz laboratory in Seville and the Villadental center in Madrid, located in San Sebastián de los Reyes.
Corus goes on and on. The Spanish group of dental laboratories continues with its commitment to growth in Spain and has acquired two new laboratories in Seville and Madrid. The company based in Sant Cugat del Vallès (Barcelona) has integrated into its network the Manuel Peña Capuz laboratory, a center specialising in dental prostheses located on Martínez de Medina street in Seville. The facility works with fixed, removable and combined prostheses. In addition, Corus has integrated into its network the Villadental laboratory, directed by Ignacio Villafáñez, which is located on Calle Gomera in San Sebastián de los Reyes (Madrid). The two facilities work together to offer their products to clinics and professionals in the dental sector.
Corus has recently strengthened its position in Northern Europe with the acquisition of Nordentic.
Corus is a Barcelona-based company specialised in dental prosthetics and orthodontics. Since its creation in 2015, the company has integrated dental prosthetic laboratories distributed between Spain, France and Portugal, mainly. Corus operates as an integrated digital platform where dentists can interact with the local laboratory and the patient at the same time, guaranteeing prescription traceability and the necessary information to realise products and services tailored to the patient. Corus’ main shareholders are Careventures and Quadrum Capital. The former is a Private Equity firm with offices in Barcelona and Brussels, specialised in investments in healthcare services. Careventures has accumulated more than one hundred transactions in ten different countries, with more than 6,000 employees in the companies it manages. Quadrum Capital is a Private Equity firm with offices in Woerden and Almelo, both in the Netherlands.
The company aims to close 2022 with a turnover of €180m.
Last August, Corus acquired Nordentic, a Scandinavian company that operates in the same sector, but in Sweden, Norway and Denmark. The purchase followed another operation that the Spanish company carried out in March 2022, when Corus acquired the Dutch company Signadens. With all the operations carried out, Corus will together manage a network of more than 60 laboratories and more than 1,500 employees. The company started the year aiming for a turnover of €100m euros in 2022, but now the forecast is around €180m. This would mean doubling the turnover with which it started the year, with €73m.
The link to the article can be found here.
